+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Desmoid Tumors Market by Treatment Type, Drug Type, Tumor Location, End User, Age Group - Global Forecast to 2030- Product Image
Desmoid Tumors Market by Treatment Type, Drug Type, Tumor Location, End User, Age Group - Global Forecast to 2030- Product Image
Sale

Desmoid Tumors Market by Treatment Type, Drug Type, Tumor Location, End User, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083870
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The desmoid tumors market is experiencing significant evolution, shaped by advancements in targeted therapies, shifting care paradigms, and dynamic regulatory environments. Senior decision-makers require clear insight into these drivers to harness opportunities and mitigate risks in this specialized sector.

Market Snapshot: Desmoid Tumors Market

The Desmoid Tumors Market grew from USD 2.68 billion in 2024 to USD 2.83 billion in 2025. It is expected to continue growing at a CAGR of 5.94%, reaching USD 3.79 billion by 2030. Growth reflects an increased focus on precision oncology, a broader range of treatment options, and ongoing investments across the pharmaceutical and medical device landscape. As competitive dynamics intensify, strategic partnerships and the emergence of real-world data are influencing how organizations position their products and services. The market’s maturation is visible through deeper patient segmentation, expansion into new regional markets, and the incorporation of digital health technologies.

Scope & Segmentation: Unlocking the Market’s Full Potential

  • Treatment Types: Includes anti-hormonal therapy (Tamoxifen, Toremifene), chemotherapy (Doxorubicin-based regimens, Methotrexate and Vinblastine, Pegylated liposomal doxorubicin), cryoablation, nonsteroidal anti-inflammatory drugs (NSAIDs), radiation therapy, surgery, and targeted therapy.
  • Drug Types: Analyzes over-the-counter (OTC) and prescription drugs used in desmoid tumor management.
  • Tumor Locations: Segments market by abdominal, extra-abdominal, and intra-abdominal tumor presentations, each with unique clinical and procedural demands.
  • End Users: Evaluates the role of ambulatory surgical centers, hospitals, and specialty clinics in delivering care.
  • Age Groups: Examines adult, pediatric, and geriatric patient populations to identify shifting incidence and treatment tolerance trends.
  • Regions: Covers Americas (including United States, Canada, Brazil, Mexico, Argentina, and key US states), Europe, Middle East & Africa (detailed regional breakdown), and Asia-Pacific (with focus on Japan, Australia, China, Southeast Asia, India, and other growth regions).
  • Technology Use: Explores adoption of imaging advancements, minimally invasive cryoablation, and digital remote monitoring platforms deployed throughout the patient journey.
  • Key Companies: Assesses activities and strategies of Apotex Inc., Bayer AG, Bristol-Myers Squibb Company, SpringWorks Therapeutics, Teva Pharmaceutical Industries Ltd, and other notable players.

Key Takeaways for Decision-Makers

  • Desmoid tumors present a rare but impactful clinical challenge requiring ongoing innovation in targeted therapy and multidisciplinary care models.
  • Personalized medicine platforms and biomarker-driven research are increasingly influential, accelerating the pipeline of novel drug candidates and redefining standard-of-care frameworks.
  • Patient pathways are transitioning from reactive to proactive management through early intervention, advanced imaging, and digital support tools that enhance surveillance and adherence.
  • Strategic alliances between pharmaceutical manufacturers, device makers, and research centers are pivotal in expediting drug development and expanding the market footprint.
  • Segmentation by treatment type, patient demographic, and tumor location is informing product development, market entry plans, and value-based care initiatives.
  • Regional markets exhibit diverse adoption patterns, shaped by health infrastructure, reimbursement models, and regulatory harmonization efforts.

Tariff Impact and Adaptation

The introduction of new United States tariffs in 2025 is affecting procurement costs for pharmaceutical products and specialized equipment within the desmoid tumors market. Suppliers are responding by diversifying supply chains and considering regional partnerships to offset supply constraints and production investments. Policymakers and payers are closely monitoring how these changes may influence patient access and the pace of therapeutic innovation, requiring ongoing strategic recalibration among industry leaders.

Research Methodology & Data Sources

This report leverages a comprehensive, multi-source approach blending secondary research (peer-reviewed literature, regulatory filings) and primary research (interviews with clinical experts and key stakeholders). Quantitative data aggregation and qualitative analysis are applied alongside peer review for data consistency, ensuring accuracy and reliability for senior decision-making.

Why This Report Matters

  • Supports evidence-based investment and partnership decisions by delivering granular segmentation and regional intelligence on the desmoid tumors market.
  • Equips leaders with actionable insights on evolving patient needs, technology adoption, and competitive positioning for sustainable expansion and operational excellence.
  • Clarifies complex regulatory and reimbursement landscapes, enabling strategy alignment for both established and emerging market players.

Conclusion

The desmoid tumors market is undergoing rapid transformation, driven by innovative therapies, responsive policy, and a continuous focus on patient-centric care. In-depth analysis enables leaders to adapt to evolving challenges and leverage new opportunities, supporting both growth and improved patient outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Desmoid Tumors Market, by Treatment Type
8.1. Introduction
8.2. Anti-Hormonal Therapy
8.2.1. Tamoxifen
8.2.2. Toremifene
8.3. Chemotherapy
8.3.1. Doxorubicin-based regimens
8.3.2. Methotrexate and Vinblastine
8.3.3. Pegylated liposomal doxorubicin
8.4. Cryoablation
8.5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
8.6. Radiation Therapy
8.7. Surgery
8.8. Targeted Therapy
9. Desmoid Tumors Market, by Drug Type
9.1. Introduction
9.2. OTC Drugs
9.3. Prescription Drugs
10. Desmoid Tumors Market, by Tumor Location
10.1. Introduction
10.2. Abdominal
10.3. Extra-Abdominal
10.4. Intra-Abdominal
11. Desmoid Tumors Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Desmoid Tumors Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Desmoid Tumors Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Desmoid Tumors Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Desmoid Tumors Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Apotex Inc.
16.3.2. Baxter International, Inc
16.3.3. Bayer AG
16.3.4. Bristol-Myers Squibb Company
16.3.5. Cipla Limited
16.3.6. Dr Reddys Laboratories Limited
16.3.7. Encapsula NanoSciences LLC
16.3.8. Fermion Oy by Orion Corporation
16.3.9. Hetero Healthcare Limited.
16.3.10. Immunome, Inc.
16.3.11. Intelicure Lifesciences
16.3.12. Iterion Therapeutics
16.3.13. Johnson & Johnson Services, Inc.
16.3.14. Mayne Pharma Group Limited
16.3.15. Medichem, S.A.
16.3.16. Natco Pharma Limited
16.3.17. Novartis AG
16.3.18. Pfizer Inc.
16.3.19. SpringWorks Therapeutics, Inc.
16.3.20. Sun Pharmaceutical Industries Limited
16.3.21. Synthon International Holding B.V.
16.3.22. Teva Pharmaceutical Industries Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DESMOID TUMORS MARKET MULTI-CURRENCY
FIGURE 2. DESMOID TUMORS MARKET MULTI-LANGUAGE
FIGURE 3. DESMOID TUMORS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DESMOID TUMORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DESMOID TUMORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DESMOID TUMORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DESMOID TUMORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DESMOID TUMORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DESMOID TUMORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DESMOID TUMORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DESMOID TUMORS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DESMOID TUMORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DESMOID TUMORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DESMOID TUMORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DESMOID TUMORS MARKET SIZE, BY TAMOXIFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DESMOID TUMORS MARKET SIZE, BY TOREMIFENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DESMOID TUMORS MARKET SIZE, BY DOXORUBICIN-BASED REGIMENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DESMOID TUMORS MARKET SIZE, BY METHOTREXATE AND VINBLASTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DESMOID TUMORS MARKET SIZE, BY PEGYLATED LIPOSOMAL DOXORUBICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DESMOID TUMORS MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DESMOID TUMORS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DESMOID TUMORS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DESMOID TUMORS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DESMOID TUMORS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DESMOID TUMORS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DESMOID TUMORS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DESMOID TUMORS MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DESMOID TUMORS MARKET SIZE, BY EXTRA-ABDOMINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DESMOID TUMORS MARKET SIZE, BY INTRA-ABDOMINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DESMOID TUMORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DESMOID TUMORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DESMOID TUMORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DESMOID TUMORS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DESMOID TUMORS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DESMOID TUMORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES DESMOID TUMORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 54. CANADA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 55. CANADA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. MEXICO DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 62. MEXICO DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 95. GERMANY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 97. GERMANY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 98. GERMANY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 100. GERMANY DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. GERMANY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. FRANCE DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 103. FRANCE DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 104. FRANCE DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 105. FRANCE DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 107. FRANCE DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. FRANCE DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. ITALY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. ITALY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 118. ITALY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 119. ITALY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. ITALY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 121. ITALY DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ITALY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. SPAIN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. SPAIN DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 125. SPAIN DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 126. SPAIN DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. DENMARK DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. DENMARK DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 165. QATAR DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. QATAR DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 167. QATAR DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 168. QATAR DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 169. QATAR DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 170. QATAR DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. QATAR DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. FINLAND DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 174. FINLAND DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 175. FINLAND DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 177. FINLAND DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. FINLAND DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. EGYPT DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 194. EGYPT DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 195. EGYPT DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 196. EGYPT DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 197. EGYPT DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 198. EGYPT DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. EGYPT DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 200. TURKEY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. TURKEY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 202. TURKEY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 203. TURKEY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 205. TURKEY DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. TURKEY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. NORWAY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 216. NORWAY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 217. NORWAY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 219. NORWAY DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NORWAY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. POLAND DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. POLAND DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 223. POLAND DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 224. POLAND DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 225. POLAND DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 226. POLAND DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. POLAND DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 243. CHINA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 244. CHINA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 245. CHINA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 246. CHINA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 247. CHINA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 248. CHINA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. CHINA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. INDIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 252. INDIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 253. INDIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 254. INDIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 255. INDIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. INDIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. JAPAN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 258. JAPAN DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 259. JAPAN DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 260. JAPAN DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 262. JAPAN DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. JAPAN DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 285. THAILAND DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 286. THAILAND DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 287. THAILAND DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 288. THAILAND DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 290. THAILAND DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. THAILAND DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 327. DESMOID TUMORS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 328. DESMOID TUMORS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Desmoid Tumors market report include:
  • Apotex Inc.
  • Baxter International, Inc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr Reddys Laboratories Limited
  • Encapsula NanoSciences LLC
  • Fermion Oy by Orion Corporation
  • Hetero Healthcare Limited.
  • Immunome, Inc.
  • Intelicure Lifesciences
  • Iterion Therapeutics
  • Johnson & Johnson Services, Inc.
  • Mayne Pharma Group Limited
  • Medichem, S.A.
  • Natco Pharma Limited
  • Novartis AG
  • Pfizer Inc.
  • SpringWorks Therapeutics, Inc.
  • Sun Pharmaceutical Industries Limited
  • Synthon International Holding B.V.
  • Teva Pharmaceutical Industries Ltd

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.79 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Desmoid Tumors Market Report 2025 - Product Image

Desmoid Tumors Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Desmoid Tumors - Pipeline Insight, 2025 - Product Image

Desmoid Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Aggressive Fibromatosis Market by Treatment Type, End User, Distribution Channel, Line Of Therapy - Global Forecast to 2030 - Product Image

Aggressive Fibromatosis Market by Treatment Type, End User, Distribution Channel, Line Of Therapy - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Chemotherapy Market by Product Type, Application, Route Of Administration, End User, Distribution Channel, Therapy Line, Mode Of Treatment, Age Group - Global Forecast to 2030 - Product Image

Chemotherapy Market by Product Type, Application, Route Of Administration, End User, Distribution Channel, Therapy Line, Mode Of Treatment, Age Group - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Tumor Necrosis Factor Inhibitor Drugs Market Size, Share & Trends Analysis Report By Product (Humira, Enbrel Remicade, Simponi/Simponi Aria, Cimzia), By Application, By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Tumor Necrosis Factor Inhibitor Drugs Market Size, Share & Trends Analysis Report By Product (Humira, Enbrel Remicade, Simponi/Simponi Aria, Cimzia), By Application, By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.